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Marc Uhlarz4, Thomas Herrmannsdörfer4, John Lucocq5, Wesam Gamal6, Pierre Bagnaninchi6, 
Scott Semple7 & Donald M Salter3
The use of stem cells to support tissue repair is facilitated by loading of the therapeutic cells with 
magnetic nanoparticles (MNPs) enabling magnetic tracking and targeting. Current methods for 
magnetizing cells use artificial MNPs and have disadvantages of variable uptake, cellular cytotoxicity 
and loss of nanoparticles on cell division. Here we demonstrate a transgenic approach to magnetize 
human mesenchymal stem cells (MSCs). MSCs are genetically modified by transfection with the mms6 
gene derived from Magnetospirillum magneticum AMB-1, a magnetotactic bacterium that synthesises 
single-magnetic domain crystals which are incorporated into magnetosomes. Following transfection of 
MSCs with the mms6 gene there is bio-assimilated synthesis of intracytoplasmic magnetic nanoparticles 
which can be imaged by MR and which have no deleterious effects on cell proliferation, migration or 
differentiation. The assimilation of magnetic nanoparticle synthesis into mammalian cells creates a real 
and compelling, cytocompatible, alternative to exogenous administration of MNPs.
MSCs have wide therapeutic potential for tissue repair and in cancer therapy but problems relating to targeting, 
engraftment and localisation persist. Labelling of MSCs with superparamagnetic iron oxide nanoparticles allows 
in vivo tracking by MR imaging and the potential to target cells to sites of injury or surgical implants to facilitate 
tissue repair1–4. Identifying the optimal method to magnetize MSCs has proven challenging. Unlike phagocytic 
cells, such as macrophages, MSCs have a relatively poor intrinsic capacity to ingest extrinsically applied MNPs, 
although this may be improved by the use of gene transfection agents5 or coating of MNPs with a range of sub-
stances including starch, poly aspartic acid and dextran sulphate6. However, uptake of MNPs by MSCs is variable 
over a population and may have detrimental effects on cell proliferation and migration7. Furthermore, the efficacy 
of MSC imaging, targeting and retention may be compromised by dilution of MNP content in progeny following 
proliferation and the possibility of MNP release and uptake by alternate cells. An alternative approach to mag-
netise MSCs would be to promote de novo synthesis of intracellular MNPs as occurs naturally in magnetotactic 
bacteria8,9. These bacteria contain a unique intracellular organelle, the magnetosome, which comprises a mag-
netic nanoparticle, typically magnetite (Fe3O4) surrounded by a lipid bilayer membrane10,11. Magnetosome for-
mation is dependent on a conserved region within magnetotactic bacterial DNA called the magnetosome island 
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(MAI) comprising mamAB, mamGFDC, mms6 and mamXY operons12. The mms6 operon comprises the genes 
mgr4074, mms6, mmsF, mms36 and mms48 and their contribution to magnetosome biogenesis is beginning to be 
understood13. Mms6 promotes the formation of uniform isomorphic superparamagnetic magnetite nano-crystals 
and helps regulate the crystal morphology of magnetite14. Significantly, recombinant Mms6 binds iron and aids 
formation of magnetite particles in vitro that are similar to those of magnetosomes13. Here we show that transfec-
tion of human MSCs with the magnetobacterial gene mms6 is sufficient to allow de novo synthesis of intracellular 
magnetic nanoparticles without functional detriment facilitating theragnostic applications of magnetic MSCs.
Results
mms6 expression and nanoparticle formation in human MSCs. The Magnetospirillum magne-
ticum AMB-1 mms6 DNA bacterial sequence was codon optimized for mammalian expression and a Kozak 
sequence added then synthesized. The optimized sequence was synthesised by MRGene GmbH, Germany and 
cloned in their proprietary vector with SacI and KpnI restriction sites. The synthetic mms6 gene was cloned into 
a pcDNA3.1 expression vector and transfected into human adipocyte derived MSCs with either X-tremeGENE 
HP or FugeneHD. Cells were cultured in the presence of 34 mM ferric quinate which is frequently used as a 
source of iron for magnetobacterial culture and magnetosome formation15. Expression of the mms6 gene in the 
transfected cells at 10, 15 and 21 days post-transfection was confirmed by RT-PCR (Supplementary Fig. 1). Sanger 
DNA sequencing of the PCR transcripts of the mms6 gene 10, 15 and 21 days post-transfection showed 100% 
identity with the inserted gene (Supplementary Fig. 2). Transfected cells cultured in the presence of 34 mM ferric 
quinate, after 10–14 days, had a distinct dark golden yellow appearance under light microscopy. By transmission 
electron microscopy (TEM) nanoparticles are identified within vacuoles, up to 1 μ m diameter, in the cytoplasm 
of the mms6 transfected cells at 1, 2 and 3 weeks in culture (Fig. 1a). Unlike the highly ordered cubo-octahedral 
crystals of magnetite crystals of Magnetospirillum magneticum AMB-1 in culture16, or those synthesised by partial 
oxidation of ferrous hydroxide in the presence of recombinant magnetotactic bacterial protein Mms6 in vitro17, 
the nanoparticles produced by the mms6 transfected MSCs appeared unstructured and ranged from 10 to 500 nm 
in size although it is not clear whether the larger nanoparticles are aggregates of the smaller particles. TEM 
images of untransfected MSCs in which no nanoparticles are identified and untransfected MSCs loaded with 
FluidMag DXS magnetic nanoparticles in which intracytoplasmic nano sized particles are present, are shown in 
Supplementary Fig. 3.
Intracellular nanoparticles demonstrate magnetic properties and generate MR image contrast. 
Atomic force microscopy/magnetic force microscopy (AFM/MFM) indicated that the synthesised nanoparti-
cles were magnetic. AFM/MFM studies were undertaken on FeCl3 powder used for ferric quinate formation in 
the cell culture medium, FluidMag DXS magnetic nanoparticles, MSCs loaded with FluidMag DXS magnetic 
nanoparticles and both mms6 expressing and untransfected MSCs. AFM/MFM studies with FeCl3 powder and 
FluidMag DXS magnetic nanoparticles dispersed on a glass cover slip demonstrate that the FeCl3 powder has no 
magnetic properties and that both dispersed cell free and intracellular FluidMag DXS magnetic particles could 
be detected by AFM/MFM (Supplementary Fig. 4). For AFM/MFM microscopy on intact mms6 transfected and 
untransfected MSCs 80 nm thick sections where placed on glass cover slips. Obtained data are shown in Fig. 1b. 
The topographic images (upper row) show the morphological variation of the surface with cells clearly identi-
fied. The MFM images (bottom row) show the presence of magnetic structures in the transfected cells, in the 
addition to some morphologic artefact. These features are mainly present in relation to the cell cytoplasm con-
sistent with the TEM observations. No magnetic structures were identified in the untransfected MSCs cultured 
with ferric quinate. Superconducting quantum interference device (SQUID) magnetometry was used to further 
confirm the magnetic nature of the nanoparticles synthesised by the mms6 transfected cells. Two different meas-
urement modes were used: First, we measured the temperature-dependent magnetization in a small, fixed field 
(μ 0H = 0.01 T) between body temperature, T = 310 K, and T = 5 K. Second, we measured the field dependence 
of the magnetization at human body temperature in magnetic fields up to μ 0H = 7 T. Results of these measure-
ments for MSCs at the third week after transfection are shown in Fig. 1c and d. In the main panel of Fig. 1c, the 
magnetic moment per dry-sample mass is shown after cooling in zero field to T = 5 K, then applying a small field 
of μ 0H = 0.01 T, and subsequently heating (lower leg of the curve) and cooling (upper leg of the curve) in this 
field. The inset to Fig. 1c shows the field dependence of the mass-specific magnetic moment for the same sample 
of MSCs after the third week after transfection, taken at body temperature. In combination with a high value of 
saturated moment (μ mass = 23.5 emu/g), the low coercive field of μ0Hc = 2× 10−3 T confirms the superparamag-
netic character of the nanoparticles. A temperature scaling of these features is expected for nanoparticles of the 
same material (e.g., Fe3O4) and same shape, but of different average diameters, with the blocking temperature, 
TB, increasing linearly with the average volume of the superparamagnetic particles18. As a measure of TB we took 
the intersection temperature between field-heated and field-cooled curves. Comparison with a sample of MSCs 
which were treated with commercially available FluidMag DXS Fe3O4 nanoparticles of 100 nm diameter (not 
shown) enabled estimation of the average diameter of the nanoparticles in transfected cells following one, two 
and three weeks in culture (Fig. 1d upper panel). The size of the magnetic particles is predicted to plateau at an 
average value of 12 nm after the second week. The saturated moment values for each sample, together with the 
estimated average diameter of the nanoparticles, allows estimation of the nanoparticle number after the first, 
second and third week post transfection. Contrary to the stalling of average nanoparticle diameter by week three 
there appeared to be continued production and accumulation of nanoparticles (Fig. 1d lower panel) supporting 
TEM observations. SQUID magnetometry of untransfected cells under identical culture conditions showed no 
magnetic behaviour (results not shown).
Currently, superparamagnetic iron-oxide nanoparticles (SPIONs) are being used to magnetically label stem 
cells to allow in vivo imaging by MR and to potentially aid localisation and retention of the loaded cells at the 
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site of interest19. To assess whether the mms6 transfected, MNP-bearing MSCs could be identified by MR, an 
in vitro phantom study was undertaken. Non-transfected MSCs, mms6 transfected MSCs and MSCs loaded with 
commercially available FluidMag DXS MNPs were placed in 1% agarose gel in 50 ml falcon tubes and subjected 
to MR imaging (Supplementary Fig. 5). The T2* values (ms) of the empty phantom and the phantom containing 
untransfected cells were 89.6 + 3.5 and 73.7 + 4.2 respectively. The T2* values of the mms6 transfected cells ranged 
from 24.9 + 6.8 to 39.2 + 5.9 whereas that of the commercial MNP loaded MSCs was 20.2 + 2.5 confirming their 
potential for in vivo tracking.
mms6 transfected, nanoparticle containing MSCs maintain cell proliferation, migration and 
differentiation. To assess whether mms6 transfection and assimilation of magnetic nanoparticle synthesis 
might have adverse effects on MSC function and their ability to aid specialised tissue repair, studies on cell prolif-
eration, migration and differentiation were undertaken (Fig. 2a and b). The proliferative capacity of the MSCs was 
investigated with electric cell-substrate impedance sensing (ECIS) to investigate whether mms6 transfected MSCs 
differed from wild-type. The forty gold microelectrodes per well of the ECIS instrument enabled the quantifica-
tion of cell coverage through impedance measurement in real-time (every 180s) over 4 consecutive days. No dif-
ference in the time-course cell coverage (Fig. 2a) was seen between transfected MSCs and controls. Subsequently, 
a medusa array was used with two addressable 250 μ m gold microelectrodes per well to study cell migration 
(Fig. 2b). An electric fence was applied to one of the two electrodes while on the control electrode both trans-
fected and wild-type cells, plated at high density, attached and spread on the single electrode with the same rapid 
Figure 1. Production of magnetic nanparticles by mms6 gene transfected human MSCs cultured in the 
presence of 34 mM ferric quinate. (a) TEM: scale bars upper left 2 μ m, upper right 0.5 μ m, lower left 0.2 μm, 
lower right 0.2 μ m. (b) AFM/MFM of mms6 transfected MSCs (left and central panels) and untransfected 
MSCs (right panel). The upper row demonstrates AFM topographic images whilst the lower demonstrates 
the equivalent MFM images. Magnetic particles are identified in the MFM images of as clusters of black spots 
due to attractive forces between the magnetised tip and the nanoparticles. Image widths: left panels 30 mm, 
central panels 6 mm, right panels 12 mm. (c) SQUID magnetometry. A. Magnetization of MSCs after the third 
week after mms6 transfection. Main panel: Temperature dependence of the magnetosome contribution to 
the magnetic moment after cooling in zero field and subsequent heating (lower leg) and cooling (upper leg) 
in μ0H = 0.01T, related to dry sample mass. Inset: Magnetic field dependence of the mass-specific magnetic 
moment for the same sample at body temperature. (d) Upper panel. Estimate of nanoparticle diameter based on 
the assumption that they consist of superparamagnetic Fe3O4 particles. Lower panel: estimate of nanoparticle 
number per gram of dry sample material, derived from estimated diameter and saturated magnetic moment.
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kinetics until they reached a plateau at T1. On the second electrode, the electric fence was then turned off at T1, 
allowing cells to migrate into the cell-free area and resulting in a decrease in capacitance. Migration rates20 were 
calculated (n = 3) with no statistical difference (p > 0.05) observed between transfected MSCs and wild-type con-
trol cells. Importantly, mms6 transfected MSCs also remain pluripotential when cultured in osteogenic, chondro-
genic or adipogenic media as demonstrated by RT-PCR (not shown) and histochemical staining (Fig. 2C). mms6 
transfected MSCs cultured for 3 weeks in osteogenic media expressed COL1A1 and BGLAP and stained positively 
with von Kossa stain indicating calcium deposition. Those cells cultured in chondrogenic expressed COL2A1 
and ACAN and stained positively with alcian blue, whilst culture in adipogenic media resulted in expression of 
PPARG and oil-red O staining indicating that they maintained the capacity for specific lineage differentiation.
Discussion
Cell-based therapy is an emerging area of regenerative medicine in which stem or progenitor cells are delivered 
either locally or systemically, principally by the blood stream. Major obstacles in the field, including retention of 
cells at a particular site and identifying the fate of locally or systemically injected cells21,22, are being challenged 
by loading of cells magnetic nanoparticles23–25. Currently, SPIONs are being used to magnetically label stem cells 
to allow in vivo imaging by MR and to potentially aid localisation and retention of the loaded cells at the site of 
interest19. In the current study we have demonstrated the utility of a transgenic approach using Magnetospirillum 
magneticum AMB-1 mms6 DNA bacterial sequence for magnetising MSCs without adverse effects on cell prolif-
eration, migration and differentiation.
Previous studies have demonstrated that stable transfection of mouse and human cancer cell lines with MagA, 
which encodes for a magnetotactic bacterial protein, results in increased iron labelling of the cells allowing MR 
imaging26,27. A study in which MagA was transfected into a human embryonal kidney cell line demonstrated 
intracellular production of 3–5 nm diameter nanoparticles which, following magnetic separation, were seen to 
consist primarily of magnetite28. To assess whether another magnetobacterial gene mmsF had similar properties 
to that of mms6 in our system we have recently transfected human embryonic bone marrow derived MSCs with 
a codon-optimized mmsF gene and cultured the cells under similar conditions to that of the mms6 transfected 
cells described in the current study. TEM demonstrated production of intracellular nanoparticles which were 
shown to have magnetic properties by SQUID magnetometry (Supplementary Figs 6 and 7). Thus it would appear 
that transfection of mammalian cells by a number of different MTB genes may facilitate production of magnetic 
nanoparticles. MagA is a putative iron transporter and provides an increase in total cellular iron in response to an 
extracellular iron supplement27. The mechanism by which mms6 expression results in production of intracellular 
Figure 2. Effect of intrinsic magnetic nanoparticle production on mms6 transfected MSC proliferation, 
migration and lineage differentiation. (a) Electric cell-substrate impedance sensing (ECIS) Assay. 
Proliferation of wild type (WT) and mms6 transfected MSCs over the course of 4 days. (b) Electric cell-substrate 
impedance sensing (ECIS) Assay. Capacitance measured in a medusa array demonstrating cell migration.  
(c) Histochemical demonstration of specific lineage differentiation of mms6 transfected MSCs. Left panel – von 
Kossa stain for calcium deposition in cells cultured in osteogenic medium; middle panel-safranin O staining of 
cells cultured in chondrogenic medium; right panel-oil-red O staining of cells cultured in adipogenic medium.
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magnetic nanoparticles in MSCs is not yet understood. Recombinant Mms6 protein has previously been shown 
to have iron binding activity, facilitating generation of uniform magnetic crystals by co-precipitation of ferrous 
and ferric ions29. Furthermore, work by Matsunaga and colleagues indicates that, because of a high affinity for 
iron ions and a highly charged electrostatic quality, Mms6 protein acts as a template for nucleus formation and/or 
a regulator of crystal size and morphology17,30,31. It has been proposed recently that Mms6 may self-assemble as a 
protein raft to display regular binding sites for iron ions to nucleate magnetite formation32. Interestingly, MmsF, 
encoded within the mms6 gene cluster, is also responsible for defining crystal size and morphology and may reg-
ulate magnetite crystal formation through similar mechanisms to Mms633.
Genetically modified MSCs expressing magnetic nanoparticles have considerable potential in regenerative 
medicine, both for MR imaging and for magnetic targeting by application of a magnetic field over the area of 
interest to attract and retain the labelled cells after either local or systemic injection. Typically this may be with 
an external magnet34 but increasingly magnetic implants are being developed, as in the orthopaedic field where 
insertion of magnetic scaffolds with or without permanent magnets can be used to aid healing of massive bone 
defects and chondro-osseous defects35–37, or in vascular surgery where magnetic stents can aid targeting of mag-
netised endothelial cells38. The assimilation of magnetic nanoparticle synthesis into mammalian cells creates a real 
and compelling, cytocompatible, alternative to exogenous administration of SPIONs. Importantly, any progeny of 
the cells could also synthesise their own nanoparticles, overcoming a significant practical constraint for SPION 
use. This motivates future technical development in stabilisation of expression through chromosomal integration.
Methods
Expression of mms6 in mammalian cells. Magnetospirillum magneticum AMB-1 mms6 DNA bacte-
rial sequence was codon optimized for mammalian expression and a Kozak sequence added then synthesized. 
The optimized sequence was synthesised by MRGene GmbH, Germany and cloned in their proprietary vector 
with SacI and KpnI restriction sites. The synthetic mms6 gene was then cloned into pcDNA3.1 expression vector 
(ThermoFisher Scientific) at BamH1 and EcoRI restriction sites. Transfection into the human adipose derived 
stem cells (STEMPRO® - Human Adipose-Derived Stem Cell Kit Human, Invitrogen) was carried out with either 
X-tremeGENE HP and FugeneHD transfection reagents (Roche Scientific) in accordance with manufacturer 
protocols.
mms6 gene expression. Total cellular RNA was extracted from cells by using the RNeasy Kit (Qiagen. 
Hilden. Germany). Prior to reverse transcription 1 μ g of RNA was treated with DNAse-I amplification grade 
(Sigma, USA). The cDNA synthesis was performed by treating the RNA with Oligo(dT) primers (Epicentre, USA, 
MMLV High Performance Reverse Transcriptase). After cDNA synthesis the solution was diluted with distilled 
water to a final volume of 200 μ l. A 2μ 1 aliquot of the cDNA product was amplified as follows: Denaturation at 
95 °C for 3 min, 35 cycles of amplification associated with denaturation at 95 °C for 15 s, annealing at 60 °C and 
extension at 72 °C for 1 min. The mms6 primers used were (1) internal primer pair for initial gene expression 
studies-forward: 5′ - GTGGGGCCCGATTATTCT-3′ ; reverse: 5′-TCACGCAGTTCCACTTCTTC-3′, the ampli-
fied PCR product of 108 bp was resolved in 2.5% agarose gel and (2) for gene expression and DNA sequencing 
– forward: 5′-ATGGGCGAAATGGAACGTGAAG-3′; reverse 5′-TCATGGTGGCGCCAGCGCATC-3′ .
Cell Culture. Transfected human adipose-derived stem cells were cultured according to the manufacturer’s 
instructions in MesenPRO RS™ Medium in the absence, or presence, of ferric quinate at a final concentration 
of 34 mM. For assessment of specific lineage differentiation capacity mms6 transfected MSCs were cultured 
to confluence, after which the medium was replaced with specific differentiation media including StemPro® 
Osteogenesis Differentiation media (Gibco), StemPro® Chondrogenesis Differentiation medium (Gibco) and 
StemPro® Adipogenesis Differentiation medium (Gibco) according to the manufacturer’s instructions. The MG63 
osteosarcoma cell line was used in initial gene transfection and expression studies (see Supplementary Fig. 1).
Transmission Electron Microscopy. Following monolayer culture cells were detached, fixed in 3% glutar-
aldehyde in 0.1 M sodium cacodylate buffer, pH 7.3, for 2 hours then washed in three 10 minute changes of 0.1 M 
sodium cacodylate and post-fixed in 1% osmium tetroxide in 0.1 M sodium cacodylate for 45 minutes before 
an additional three 10 minute changes of 0.1 M sodium cacodylate buffer. The samples were then dehydrated 
in 50%, 70%, 90% and 100% normal grade acetone for 10 minutes each followed by two 10-minute changes in 
analar acetone before being embedded in Araldite resin. Sections were cut on a Reichert OMU4 ultramicrotome 
(Leica Microsystems (UK) Ltd, Milton Keynes), stained with Toluidine Blue and viewed in a light microscope 
to select suitable areas for investigation. Ultrathin sections, 60 nm thick, were cut from selected areas, stained in 
uranyl acetate and lead citrate then viewed in a Phillips CM120 transmission electron microscope (FEI UK Ltd, 
Cambridge, England). Images were taken on a Gatan Orius CCD camera (Gatan UK, Oxon, England).
Atomic Force Microscopy (AFM) and Magnetic Force Microscopy (MFM). AFM-MFM imaging was 
performed under ambient conditions with a commercial scanning probe microscope, Bioscope II (Bruker-Nano) 
using magnetic probes (MESP-RC cantilevers) that were properly magnetised just before their use. Untransfected 
and transfected cells were embedded in Araldite resin, and 80 nm thick sections were cut on a Reichert OMU4 
ultramicrotome (Leica Microsystems (UK) Ltd, Milton Keynes) and placed on glass coverslips for AFM-MFM 
imaging. To obtain simultaneous topographic and magnetic images the LiftMode technique was used. First, the 
tip is scanned over the surface of the sample to record obtain the topographic information using the taping mode. 
Then the tip is raised just above the sample surface by an offset (20 nm) called lift height. The surface topography 
from the initial scan is added to the lift height to maintain constant separation during the lifted scan. Magnetic 
interactions are detected during this second pass and information about the magnetic field above a sample are 
gathered. Using the LiftMode technique, topographical features are virtually absent from the MFM images.
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Magnetic Property Analysis. Magnetization measurements were performed with a superconducting 
quantum interference device (SQUID) magnetometer. This instrument measures the total magnetic moment 
of a sample, including all atomic and molecular magnetic contributions. Magnetization data were taken at tem-
peratures 5 K < T < 350 K using a liquid-He cooled variable-temperature insert installed in the commercial 
SQUID-magnetometer apparatus (MPMS, Quantum Design Inc., San Diego, USA).
Samples were centrifuged for 5 minutes at 5000 g and the supernatant fluid was decanted. The remaining cell 
material was dried carefully for 12 hours at room temperature. Then, the sample material was weighed using a 
Sartorius Micro M3P balance to derive mass-specific values, transferred to the sample holder, and measured at 
respective fields and temperatures. Initially, the properties of a control sample of transfected MSCs grown in 
non-iron containing media were determined. This diamagnetic contribution of the pure-protein component to 
magnetization was later subtracted from the measured properties of the other sample materials to obtain the 
magnetization component originating from the nanoparticles. Two different measurement modes were used for 
all samples: First, we measured the temperature-dependent magnetization in a small, fixed field (μ 0H = 0.01T) 
between body temperature, T = 310 K, and T = 5 K. Second, we measured the field dependence of the magnetiza-
tion at body temperature in magnetic fields up to μ 0H = 7T. During the measurements, the magnetic field, gener-
ated by a superconducting coil, was either held constant while measuring at varying temperatures, or was swept 
at constant temperature, while the samples were consistently moved through a pick-up coil system connected to 
the SQUID via a flux transformer.
MR Imaging. MSCs were transfected described above and cultured for three weeks, harvested and fixed in 
1:1 methanol:acetone for 5 minutes and loaded in 1% agarose gel in 50 ml falcon tubes. Magnetic resonance was 
performed using the head matrix coil of a 3 T MRI system (MAGNETOM Verio, Siemens AG, Healthcare Sector, 
Erlangen, Germany). Phantoms were suspended in a water bath to reduce artefact. Multi-gradient-echo T2* 
acquisitions were acquired from 2.7–21.3 ms and used to generate T2* values (ms) using a standard least-squares 
fitting routine in Matlab (Mathworks).
Electric cell-substrate impedance sensing (ECIS) Assay. Impedance characterisation of transfected 
cells behaviour was conducted with the ECIS system (ECIS Zθ , Applied Biophysics, NY, USA). In brief, cells 
were grown on eight-well ECIS arrays (8W10+ ; Applied Biophysics, NY, USA) containing forty 250-μ m gold 
microelectrodes per well. Measurements were performed directly in cell culture medium, allowing real-time 
monitoring. Both the ECIS arrays and the measurement station were kept in an incubator with high humidity at 
37 °C and 5% CO2. Wild type and transfected cells were plated at low concentration in three wells each (N = 3) 
at t = 0, and the impedance was measured against time in an incubator with a sampling frequency of 1/180s for 
several days. Impedance of a cell-free electrode in media was also measured as a background signal. For the 
Medusa array studies two independently addressable 250 μ m diameter gold microelectrodes per well were used. 
One of the electrodes was submitted to a high electric field “fence” (40 kHz, 1 mA, 1s, 5 cycles per min) to prevent 
cell attachment, while cells were free to attach on the second one. When the so-called electric fence was lifted cell 
migration occurred to repopulate the cell-free electrode. Matlab was then used to perform one-way ANOVA and 
Tukey–Kramer multicomparison tests to determine whether the groups under investigation were significantly 
different from each other.
References
1. Frangioni, J. V. & Hajjar, R. J. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110, 3378–3383, 
doi: 10.1161/01.CIR.0000149840.46523.FC (2004).
2. Oshima, S., Kamei, N., Nakasa, T., Yasunaga, Y. & Ochi, M. Enhancement of muscle repair using human mesenchymal stem cells 
with a magnetic targeting system in a subchronic muscle injury model. J Orthop Sci 19, 478–488, doi: 10.1007/s00776-014-0548-9 
(2014).
3. Polyak, B. et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc 
Natl Acad Sci USA 105, 698–703, doi: 10.1073/pnas.0708338105 (2008).
4. Connell, J. J., Patrick, P. S., Yu, Y., Lythgoe, M. F. & Kalber, T. L. Advanced cell therapies: targeting, tracking and actuation of cells 
with magnetic particles. Regen Med, doi: 10.2217/rme.15.36 (2015).
5. Wang, Z. & Cuschieri, A. Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and 
spatial distribution of the intracellular iron. Int J Mol Sci 14, 9111–9125, doi: 10.3390/ijms14059111 (2013).
6. Gazeau, F. & Wilhelm, C. Magnetic labeling, imaging and manipulation of endothelial progenitor cells using iron oxide 
nanoparticles. Future Med Chem 2, 397–408, doi: 10.4155/fmc.09.165 (2010).
7. Gao, Z., Zhang, L., Hu, J. & Sun, Y. Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded 
nanoparticles. Nanomedicine 9, 174–184, doi: 10.1016/j.nano.2012.06.003 (2013).
8. Schuler, D. & Frankel, R. B. Bacterial magnetosomes: microbiology, biomineralization and biotechnological applications. Appl 
Microbiol Biotechnol 52, 464–473 (1999).
9. Schuler, D. Genetics and cell biology of magnetosome formation in magnetotactic bacteria. FEMS Microbiol Rev 32, 654–672, doi: 
10.1111/j.1574-6976.2008.00116.x (2008).
10. Frankel, R. B. Magnetic guidance of organisms. Annu Rev Biophys Bioeng 13, 85–103, doi: 10.1146/annurev.bb.13.060184.000505 
(1984).
11. Grunberg, K. et al. Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense. Appl 
Environ Microbiol 70, 1040–1050 (2004).
12. Murat, D., Quinlan, A., Vali, H. & Komeili, A. Comprehensive genetic dissection of the magnetosome gene island reveals the step-
wise assembly of a prokaryotic organelle. Proc Natl Acad Sci USA 107, 5593–5598, doi: 10.1073/pnas.0914439107 (2010).
13. Lohsse, A. et al. Genetic dissection of the mamAB and mms6 operons reveals a gene set essential for magnetosome biogenesis in 
Magnetospirillum gryphiswaldense. J Bacteriol 196, 2658–2669, doi: 10.1128/JB.01716-14 (2014).
14. Lohsse, A. et al. Functional analysis of the magnetosome island in Magnetospirillum gryphiswaldense: the mamAB operon is 
sufficient for magnetite biomineralization. PLoS One 6, e25561, doi: 10.1371/journal.pone.0025561 (2011).
15. Frankel, R. B. & Blakemore, R. P. Magnetite and magnetotaxis in microorganisms. Adv Exp Med Biol 238, 321–330 (1988).
www.nature.com/scientificreports/
7Scientific RepoRts | 7:39755 | DOI: 10.1038/srep39755
16. Tanaka, M., Mazuyama, E., Arakaki, A. & Matsunaga, T. MMS6 protein regulates crystal morphology during nano-sized magnetite 
biomineralization in vivo. J Biol Chem 286, 6386–6392, doi: 10.1074/jbc.M110.183434 (2011).
17. Amemiya, Y., Arakaki, A., Staniland, S. S., Tanaka, T. & Matsunaga, T. Controlled formation of magnetite crystal by partial oxidation 
of ferrous hydroxide in the presence of recombinant magnetotactic bacterial protein Mms6. Biomaterials 28, 5381–5389, doi: 
10.1016/j.biomaterials.2007.07.051 (2007).
18. Candela, G. A. & Haines, R. A. Method for Determining the Region of Superparamagnetism. Appl Phys Lett 34, 868–870, doi: 
10.1063/1.90705 (1979).
19. Tang, C., Russell, P. J., Martiniello-Wilks, R., Rasko, J. E. & Khatri, A. Concise review: Nanoparticles and cellular carriers-allies in 
cancer imaging and cellular gene therapy? Stem Cells 28, 1686–1702, doi: 10.1002/stem.473 (2010).
20. Gamal, W. et al. Real-time quantitative monitoring of hiPSC-based model of macular degeneration on Electric Cell-substrate 
Impedance Sensing microelectrodes. Biosens Bioelectron 71, 445–455, doi: 10.1016/j.bios.2015.04.079 (2015).
21. Chavakis, E., Urbich, C. & Dimmeler, S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell 
Cardiol 45, 514–522, doi: 10.1016/j.yjmcc.2008.01.004 (2008).
22. Abdallah, B. M. & Kassem, M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 15, 109–116, 
doi: 10.1038/sj.gt.3303067 (2008).
23. Andreas, K. et al. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for 
MRI tracking. Biomaterials 33, 4515–4525, doi: 10.1016/j.biomaterials.2012.02.064 (2012).
24. Chemaly, E. R., Yoneyama, R., Frangioni, J. V. & Hajjar, R. J. Tracking stem cells in the cardiovascular system. Trends Cardiovasc Med 
15, 297–302, doi: 10.1016/j.tcm.2005.09.004 (2005).
25. Feng, Y. et al. In vitro targeted magnetic delivery and tracking of superparamagnetic iron oxide particles labeled stem cells for 
articular cartilage defect repair. J Huazhong Univ Sci Technolog Med Sci 31, 204–209, doi: 10.1007/s11596-011-0253-2 (2011).
26. Goldhawk, D. E. et al. Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging. 
Mol Imaging 8, 129–139 (2009).
27. Sengupta, A. et al. Biophysical features of MagA expression in mammalian cells: implications for MRI contrast. Front Microbiol 5, 
29, doi: 10.3389/fmicb.2014.00029 (2014).
28. Zurkiya, O., Chan, A. W. & Hu, X. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI 
reporter. Magn Reson Med 59, 1225–1231, doi: 10.1002/mrm.21606 (2008).
29. Prozorov, T. et al. Protein-Mediated Synthesis of Uniform Superparamagnetic Magnetite Nanocrystals. Advanced Functional 
Materials 17, 951–957, doi: 10.1002/adfm.200600448 (2007).
30. Arakaki, A., Masuda, F., Amemiya, Y., Tanaka, T. & Matsunaga, T. Control of the morphology and size of magnetite particles with 
peptides mimicking the Mms6 protein from magnetotactic bacteria. J Colloid Interface Sci 343, 65–70, doi: 10.1016/j.jcis.2009.11.043 
(2010).
31. Arakaki, A., Yamagishi, A., Fukuyo, A., Tanaka, M. & Matsunaga, T. Co-ordinated functions of Mms proteins define the surface 
structure of cubo-octahedral magnetite crystals in magnetotactic bacteria. Mol Microbiol 93, 554–567, doi: 10.1111/mmi.12683 
(2014).
32. Staniland, S. S. & Rawlings, A. E. Crystallizing the function of the magnetosome membrane mineralization protein Mms6. Biochem 
Soc Trans 44, 883–890, doi: 10.1042/BST20160057 (2016).
33. Murat, D. et al. The magnetosome membrane protein, MmsF, is a major regulator of magnetite biomineralization in 
Magnetospirillum magneticum AMB-1. Mol Microbiol 85, 684–699, doi: 10.1111/j.1365-2958.2012.08132.x (2012).
34. Shen, Y. et al. Comparison of Magnetic Intensities for Mesenchymal Stem Cell Targeting Therapy on Ischemic Myocardial Repair: 
High Magnetic Intensity Improves Cell Retention but Has No Additional Functional Benefit. Cell Transplant, doi: 
10.3727/096368914X685302 (2014).
35. De Santis, R. et al. Towards the Design of 3D Fiber-Deposited Poly(epsilon-caprolactone)/lron-Doped Hydroxyapatite 
Nanocomposite Magnetic Scaffolds for Bone Regeneration. J Biomed Nanotechnol 11, 1236–1246 (2015).
36. Panseri, S. et al. Innovative magnetic scaffolds for orthopedic tissue engineering. Journal of Biomedical Materials Research Part A 
100A, 2278–2286, doi: 10.1002/jbm.a.34167 (2012).
37. Tampieri, A. et al. Magnetic bioinspired hybrid nanostructured collagen-hydroxyapatite scaffolds supporting cell proliferation and 
tuning regenerative process. ACS Appl Mater Interfaces 6, 15697–15707, doi: 10.1021/am5050967 (2014).
38. Zohra, F. T., Medved, M., Lazareva, N. & Polyak, B. Functional behavior and gene expression of magnetic nanoparticle-loaded 
primary endothelial cells for targeting vascular stents. Nanomedicine (Lond) 10, 1391–1406, doi: 10.2217/nnm.15.13 (2015).
Acknowledgements
This work was funded under the FP7 EU project “MAGISTER”. Grant Number: NMP3-LA-2008-214685 and 
additionally supported through a MRC Confidence in Concept scheme award to the University of Edinburgh.
Author Contributions
A.E. and G.R. contributed equally as first authors. D.M.S. and A.E. conceived, designed and oversaw all of the 
studies, collection of results, interpretation of the data and writing of the manuscript and were responsible for the 
primary undertaking, completion and supervision of experiments. G.R. provided input into experimental design 
and was responsible for initial gene design, transfection, cell culture studies and TEM. R.M. was responsible for 
the AFM/MFM analysis. L.L. and A.A. assisted with gene transfections, cell culture, RTPCR, DNA sequencing, 
SQUID magnetometry of untransfected cell samples and TEM. M.U. and T.H. were responsible for SQUID 
magnetometry experiments on transfected cells. J.L. assisted with TEM analysis, W.G. and P.B. were responsible 
for the ECIS experiment and analysis. S.S was responsible for the MR studies. D.M.S., A.E., G.R., P.B. and R.M. 
contributed to drafting the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Elfick, A. et al. Biosynthesis of magnetic nanoparticles by human mesenchymal stem 
cells following transfection with the magnetotactic bacterial gene mms6 . Sci. Rep. 7, 39755; doi: 10.1038/
srep39755 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
www.nature.com/scientificreports/
8Scientific RepoRts | 7:39755 | DOI: 10.1038/srep39755
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
